Stemtech (STEK) EBIAT (2020 - 2025)
Stemtech's EBIAT history spans 6 years, with the latest figure at -$812541.0 for Q3 2025.
- For Q3 2025, EBIAT rose 30.77% year-over-year to -$812541.0; the TTM value through Sep 2025 reached -$3.0 million, up 43.56%, while the annual FY2024 figure was -$3.8 million, 30.58% up from the prior year.
- EBIAT for Q3 2025 was -$812541.0 at Stemtech, down from -$293145.0 in the prior quarter.
- Across five years, EBIAT topped out at $17.4 million in Q3 2022 and bottomed at -$25.0 million in Q2 2022.
- The 5-year median for EBIAT is -$812541.0 (2025), against an average of -$1.4 million.
- The largest YoY upside for EBIAT was 427.46% in 2022 against a maximum downside of 3117.15% in 2022.
- A 5-year view of EBIAT shows it stood at -$848155.0 in 2021, then skyrocketed by 46.49% to -$453827.0 in 2022, then tumbled by 310.4% to -$1.9 million in 2023, then skyrocketed by 78.88% to -$393445.0 in 2024, then plummeted by 106.52% to -$812541.0 in 2025.
- Per Business Quant, the three most recent readings for STEK's EBIAT are -$812541.0 (Q3 2025), -$293145.0 (Q2 2025), and -$1.5 million (Q1 2025).